A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Wellcome Open Res
Autori principali: Kestelyn, Evelyne, Dung, Nguyen Thi Phuong, Lam Minh, Yen, Hung, Le Manh, Quan, Nguyen Minh, Dung, Nguyen Thanh, Minh, Ngo Ngoc Quang, Xuan, Tran Chanh, Phong, Nguyen Thanh, Ninh Thi Thanh, Van, Donovan, Joseph, Tu, Tran Nguyen Hoang, Nhat, Le Thanh Hoang, Truong, Nguyen Thanh, Man, Dinh Nguyen Huy, Thao, Huynh Phuong, Ngoc, Nghiêm My, Lam, Vo Thanh, Phat, Huynh Hong, Phuong, Phan Minh, Geskus, Ronald B., Ha, Vo Thi Nhi, Quang, Nguyen Ngo, Tran Tinh, Hien, Tan, Le Van, Thwaites, Guy E., Day, Jeremy N., Chau, Nguyen Van Vinh
Natura: Artigo
Lingua:Inglês
Pubblicazione: F1000 Research Limited 2020
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://ncbi.nlm.nih.gov/pubmed/33110944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15936.1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi